Hypertriglyceridemia in obese subjects: caused by reduced apolipoprotein A5 plasma levels?
Heeren
Joerg
J
Department of Biochemistry and Molecular Biology II: Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany. heeren@uke.uni-hamburg.de
Merkel
Martin
M
D000818:Animals; D000072040:Apolipoprotein A-V; D001054:Apolipoproteins A / Q000097:blood*; D002460:Cell Line; D005227:Fatty Acids / Q000737:chemistry; D006239:Haplotypes; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood* / Q000150:complications*; D020738:Leptin / Q000737:chemistry; D008071:Lipoprotein Lipase / Q000378:metabolism; D008954:Models, Biological; D009765:Obesity / Q000097:blood* / Q000150:complications*; D051381:Rats; D011924:Rats, Zucker; D015398:Signal Transduction; D014280:Triglycerides / Q000097:blood / Q000378:metabolism
C437704:APOA5 protein, human; D000072040:Apolipoprotein A-V; D001054:Apolipoproteins A; D005227:Fatty Acids; D020738:Leptin; D014280:Triglycerides; D008071:Lipoprotein Lipase